Human Stem Cell Models of Neurodegeneration: Exploiting In Vitro Phenotypes to Support Drug Delivery
Human stem cell models offer invaluable insights into how neurodegenerative diseases such as Alzheimer’s and Parkinson’s affect the brain. In this article hosted by Oxford Global, Dr. Clare Jones, Chief Scientific Officer at Talisman Therapeutics, describes how Talisman develops and applies the most translationally relevant in vitro models of neurodegeneration.